These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38139834)

  • 1. Advantages of Long-Wavelength Photosensitizer
    Plotnikova E; Nemtsova E; Abakumov M; Suvorov N; Pankratov A; Shegai P; Kaprin A
    Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photophysical properties and in vitro and in vivo photoinduced antitumor activity of cationic salts of meso-tetrakis(N-alkyl-3-pyridyl)bacteriochlorins.
    Yakubovskaya RI; Plotnikova EА; Plyutinskaya AD; Morozova NB; Chissov VI; Makarova EA; Dudkin SV; Lukyanets EA; Vorozhtsov GN
    J Photochem Photobiol B; 2014 Jan; 130():109-14. PubMed ID: 24316046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating phototherapeutic indices from in vitro to in vivo photodynamic therapy with bacteriochlorins.
    Luz AFS; Pucelik B; Pereira MM; Dąbrowski JM; Arnaut LG
    Lasers Surg Med; 2018 Jul; 50(5):451-459. PubMed ID: 29714399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodiagnosis and photodynamic effects of bacteriochlorin-naphthalimide conjugates on tumor cells and mouse model.
    Morozova NB; Pavlova MA; Plyutinskaya AD; Pankratov AA; Efendiev KT; Semkina AS; Pritmov DA; Mironov AF; Panchenko PA; Fedorova OA
    J Photochem Photobiol B; 2021 Oct; 223():112294. PubMed ID: 34500215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a bacteriochlorin-based photosensitizer's anti-tumor effect in vitro and in vivo.
    Zhang LJ; O'Shea D; Zhang CY; Yan YJ; Wang L; Chen ZL
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1921-30. PubMed ID: 25804838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitizing effectiveness of a novel chlorin-based photosensitizer for photodynamic therapy in vitro and in vivo.
    Zhang LJ; Bian J; Bao LL; Chen HF; Yan YJ; Wang L; Chen ZL
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1527-36. PubMed ID: 24863752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between porphin, chlorin and bacteriochlorin derivatives for photodynamic therapy: Synthesis, photophysical properties, and biological activity.
    Zhu W; Gao YH; Liao PY; Chen DY; Sun NN; Nguyen Thi PA; Yan YJ; Wu XF; Chen ZL
    Eur J Med Chem; 2018 Dec; 160():146-156. PubMed ID: 30336449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of photodynamic therapy with a chlorin derivative in vitro and in vivo.
    Wang LX; Li JW; Huang JY; Li JH; Zhang LJ; O'Shea D; Chen ZL
    Tumour Biol; 2015 Sep; 36(9):6839-47. PubMed ID: 25846737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and tissue distribution characteristics of the novel photosensitizer 3
    Wang L; Dong Y; Cao L; Sun Y; Li Y; Zhao W
    Se Pu; 2021 Dec; 39(12):1291-1297. PubMed ID: 34812000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilicity of Bacteriochlorin-Based Photosensitizers as a Determinant for PDT Optimization through the Modulation of the Inflammatory Mediators.
    Pucelik B; Arnaut LG; Dąbrowski JM
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31861531
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective
    Sharma SK; Krayer M; Sperandio FF; Huang L; Huang YY; Holten D; Lindsey JS; Hamblin MR
    J Porphyr Phthalocyanines; 2013 Jan; 17(1-2):73-85. PubMed ID: 23956614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens.
    Rocha LB; Gomes-da-Silva LC; Dąbrowski JM; Arnaut LG
    Eur J Cancer; 2015 Sep; 51(13):1822-30. PubMed ID: 26139544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary screening of substances-photosensibilizers of the bacteriochlorin range for photodynamic therapy of malignant neoplasms].
    Plotnikova EA; Grin MA; Ostroverkhov PV; Pantushenko IV; Yakubovskaya RI; Kaprin AD
    Biomed Khim; 2018 Jun; 64(3):283-289. PubMed ID: 29964266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
    Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
    Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles.
    Abdelghany SM; Schmid D; Deacon J; Jaworski J; Fay F; McLaughlin KM; Gormley JA; Burrows JF; Longley DB; Donnelly RF; Scott CJ
    Biomacromolecules; 2013 Feb; 14(2):302-10. PubMed ID: 23327610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo.
    Zhang LJ; Zhang XH; Liao PY; Sun JJ; Wang L; Yan YJ; Chen ZL
    J Photochem Photobiol B; 2016 Oct; 163():224-31. PubMed ID: 27591565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic Therapy of the Murine LM3 Tumor Using Meso-Tetra (4-N,N,N-Trimethylanilinium) Porphine.
    Colombo LL; Juarranz A; Cañete M; Villanueva A; Stockert JC
    Int J Biomed Sci; 2007 Dec; 3(4):258-62. PubMed ID: 23675051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy.
    Krzykawska-Serda M; Dąbrowski JM; Arnaut LG; Szczygieł M; Urbańska K; Stochel G; Elas M
    Free Radic Biol Med; 2014 Aug; 73():239-51. PubMed ID: 24835769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-tetrakis(M-hydroxyphenyl) bacteriochlorin.
    Rovers JP; de Jode ML; Rezzoug H; Grahn MF
    Photochem Photobiol; 2000 Sep; 72(3):358-64. PubMed ID: 10989607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.